Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI – American College of Cardiology
Debabrata Mukherjee, MD, FACC
Related Articles
CV Board – Building a New Board for Cardiovascular Medicine
Other cardiovascular organizations, including the American Heart Association (AHA), have applauded the vision and have collaborated in the development of the application. Formal support from…
Chest Pain MI Registry
As of July 1, 2023, a new version of Chest Pain – MI Registry is available. Now offering two dataset options for abstraction that provides…
Genetic Penetrance in Dilated Cardiomyopathy – American College of Cardiology
Debabrata Mukherjee, MD, FACC
Collaborative Maintenance Pathway – American College of Cardiology
This assessment option, called the Collaborative Maintenance Pathway, will be available for cardiovascular disease starting in 2019, and it will integrate lifelong learning with assessment.
PRO/CON Debate: Atrial Fibrillation Ablation in Older Adults With Heart Failure and Reduced Ejection Fraction: I Politely Disagree – American College of Cardiology
Atrial fibrillation (AF) ablation in the best of circumstances has modest success rates. There is a critical need to translate current randomized clinical trial evidence…
Clinical Performance of Mechanical Aortic Valve Prostheses – American College of Cardiology
David S. Bach, MD, FACC
Acute CV Events in Hospitalized Older Adults With RSV – American College of Cardiology
Sandra M. Oliver-McNeil, DNP, ACNP-BC, FACC
PRO/CON Debate: Atrial Fibrillation Ablation in Older Adults With Heart Failure and Reduced Ejection Fraction: Please Ablate – American College of Cardiology
Heart failure (HF) and atrial fibrillation (AF) are a bad combination, such that AF can exacerbate HF symptoms, worsen left ventricular function, and create multiple…